Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Members of the Prostate Cancer Roundtable have received a letter from the Agency for Healthcare Research and Quality (AHRQ) addressing issues raised by the Roundtable members about the draft USPSTF recommendations on use of the PSA test in screening for risk of prostate cancer.
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, testing | 2 Comments »
For our US-based readers … It appears that Rep. Kucinich’s statements on his web site (reported on this web site a few days ago) are something of a political simplification of reality.
Filed under: Diagnosis, Risk | Tagged: PSA, recommendation, screening, USPSTF | 1 Comment »
According to an announcement on the web site of Congressmen Dennis Kucinich late yesterday, HHS Secretary Kathleen Sebelius has agreed to overule the draft recommendation issued by the U.S. Preventive Services Task Force (USPSTF) related to the use of PSA testing as a means to detect prostate cancer.
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, rfisk, screening, testing | 9 Comments »
A new article published on line late Friday in the Journal of the National Cancer Institute shows “no evidence of a mortality benefit for organized annual screening in the PLCO trial compared with opportunistic screening” for prostate cancer.
Filed under: Diagnosis, Risk | Tagged: mortality, risk, screening, testing | 11 Comments »
Some readers may want to review the article on the Reuters web site entitled “Health panel takes heat on cancer screening advice.”
Filed under: Diagnosis, Risk | Tagged: screening, USPSTF | 8 Comments »
Now here’s a new perspective on the value of widespread prostate cancer screening from one of the founders of Prostate Cancer Awareness Week — Dr. David Crawford of the University of Colorado Health Science Center in Denver, CO (who is also the Chairman of the Prostate Conditions Education Council):
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: elderly, screening, testing, value | 2 Comments »
The value of regular testing of increasingly elderly men and women for risk of cancer is controversial. However, a new paper in the Archives of Internal Medicine has certainly added to our knowledge of just how widespread such testing may be … at least in the USA.
Filed under: Diagnosis, Management, Risk | Tagged: elderly, recommendation, screening, testing | 8 Comments »
We aren’t sure exactly what this adds to the recent conversations, but Gallup, the market research firm, has just provided results of a poll that asked 1,102 upstanding American adults for their opinions about cancer screening.
Filed under: Diagnosis, Risk | Tagged: Gallup, opinion, perception, public, screening | 9 Comments »
The October issue of the Canadian Journal of Urology contains an interesting and thorough review of the available data on the value of screening for prostate cancer as seen by a group including urologists, urologic oncologists, medical oncologists, radiation oncologists, and a highly regarded primary care physician.
Filed under: Diagnosis, Risk | Tagged: mortality, PSA, risk, screening, testing | Leave a Comment »
The debate over the merits and risks of widespread screening for prostate cancer using the PSA test is hardly confined to the USA. A new article (in German) in the journal Urologie A addresses exactly the same issues as have recently received so much attention here in the States.
Filed under: Diagnosis, Risk | Tagged: Diagnosis, mortality, PSA, risk, screening | 1 Comment »
On November 8, the American Urological Asociation (AUA) issued its full, formal comment letter on the US Preventive Services Task Force (USPSTF)’s draft recommendation of a “D” grade for the use of PSA screening in healthy men with no symptoms of prostate cancer. The AUA also issued a formal statement for the media.
Filed under: Diagnosis, Risk | Tagged: AUA, Diagnosis, PSA, risk, screening, USPSTF | 3 Comments »
Larry Axmaker is an 8-year prostate cancer survivor and very happy he had regular PSA screenings!
Filed under: Diagnosis, Risk | Tagged: recommendation, screening, testing, USPSTF | 1 Comment »
Ten members of the Prostate Cancer Roundtable have today submitted a joint letter to the U.S. Preventive Services Task Force commenting on the recent draft recommendation of a “D” grade for use of the PSA test in screening for prostate cancer among men who do not have symptoms that are highly suspicious for prostate cancer, [...]
Filed under: Diagnosis, Risk | Tagged: PSA testing, risk, screening, USPSTF | 1 Comment »
This week’s issue issue of the New England Journal of Medicine includes four perspective articles on the recent draft recommendation about PSA screening issued by the U.S. Preventive Services Task Force (USPSTF).
Filed under: Diagnosis, Risk | Tagged: PSA, recommendation, screening, testing, USPSTF | 5 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site